ArticleJournal of pharmaceutical policy and practice2021
Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries.
Article in Journal of pharmaceutical policy and practice, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Do subsidies reach the sick? Implementation challenges and equity implications of pharmaceutical subsidy reform in Iran: a qualitative study.International journal for equity in health · 2026Article
- Drivers of vulnerability to medicine smuggling and combat strategies: a qualitative study based on online news media analysis in Iran.BMC health services research · 2024Article
- Effects of transparent online open procurement on prices, volumes, and costs of medicines: an interrupted time series study in Ningxia, China.Frontiers in pharmacology · 2024Article
- An adapted model of cost-related medication nonadherence among older adult patients with chronic diseases: an Iranian qualitative study.BMC geriatrics · 2023Article
- Explanation of Socio-economic Inequality in Medicine Use: A Cross-sectional Analysis from Iran.Iranian journal of pharmaceutical research : IJPR · 2022Article
- Process and components of disaster risk communication in health systems: A thematic analysis.Jamba (Potchefstroom, South Africa) · 2022Article
- Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis.Health research policy and systems · 2021Article
- Economic, Cultural, and Political Requirements for Medical Tourism Development in Iran: Insights from a Fuzzy Analytical Hierarchy Process Method.Medical journal of the Islamic Republic of Iran · 2021Article
- Mapping the Financial Risk of Iran's Pharmaceutical System: A Cross-sectoral Qualitative Study.Iranian journal of pharmaceutical research : IJPRArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimThis study estimated the GDP share of pharmaceuticals in Iran based on the drivers of pharmaceutical expenditure and compared it with that of 31 members of the Organisation for Economic Cooperation and Development (OECD). SUBJECT AND
methodsThe factors contributing to pharmaceutical expenditure were identified through literature review and studied by 8 experts to classify the factors. Then, using the panel data method, a model was built to estimate the GDP share of pharmaceutical expenditure based on the extracted factors of the selected countries in Iran's model. To explain the observed differences, several regression analyses were performed based on cross-sectional data. The analyses were performed using EVIEWS software, version 10.
resultsThe explanatory variables for the selected countries in the panel model (R
conclusionIn the models of the study, factors related to the structure of the healthcare system and the pharmaceutical system contributed most to pharmaceutical expenditure as a share of GDP. Moreover, disease profiles show its predictive role in the second model for Iran.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.